InvestorsHub Logo

falconer66a

04/08/22 4:15 PM

#356796 RE: FitzyP33 #356790

Likability of a CEO determines stock prices?

...there is zero chance this CEO can commercialize anything. Someone else will have to do it.


Sure, that makes a lot of sense.

When very positive safety and efficacy data appear from the completed Phase 3 Parkinson’s disease dementia and Alzheimer’s clinical trials, the entire investment community is going to say, “Well, Anavex will never be able to gain FDA approval for the drug because a bunch of message board people don’t like the guy.”

Makes lots of sense (to some).